Common biomarker test could be misguiding treatment for some Black women with breast cancer

A common test used to decide whether breast cancer patients should get chemotherapy may be making bad recommendations for some Black women, leading them to forgo chemotherapy when it might have helped, according to new research from the University of Illinois Chicago.

Related Keywords

University Of Illinois ,Illinois ,United States ,Garth Rauscher ,Kent Hoskins ,Oana Danciu ,Hsiao Ching Huang ,School Of Public Health ,Journal Of The National Comprehensive Cancer Network ,University Of Illinois Chicago ,College Of Medicine ,University Of Illinois Cancer Center ,College Of Pharmacy ,National Comprehensive Cancer Network ,Illinois Cancer ,Breast Cancer ,Dancer ,Chemotherapy ,Biomarker ,Biotechnology ,Doctor ,Estrogen ,Gene ,Health Care ,Medicine ,Eceptor ,Research ,